Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Intangibles (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Intangibles data on record, last reported at $4.2 million in Q2 2025.

  • For Q2 2025, Intangibles changed 0.0% year-over-year to $4.2 million; the TTM value through May 2025 reached $4.2 million, changed 0.0%, while the annual FY2025 figure was $4.2 million, 0.0% changed from the prior year.
  • Intangibles reached $4.2 million in Q2 2025 per LFCR's latest filing, roughly flat from $4.2 million in the prior quarter.
  • Across five years, Intangibles topped out at $25.3 million in Q3 2021 and bottomed at $4.2 million in Q1 2021.
  • Average Intangibles over 5 years is $8.4 million, with a median of $4.2 million recorded in 2021.
  • The widest YoY moves for Intangibles: up 503.05% in 2021, down 85.97% in 2021.
  • A 5-year view of Intangibles shows it stood at $25.3 million in 2021, then tumbled by 70.78% to $7.4 million in 2022, then tumbled by 43.24% to $4.2 million in 2023, then changed by 0.0% to $4.2 million in 2024, then changed by 0.0% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Intangibles were $4.2 million in Q2 2025, $4.2 million in Q1 2025, and $4.2 million in Q4 2024.